{
    "nctId": "NCT06016790",
    "briefTitle": "Exploring a Breast Cancer Early Screening Model Based on cfDNA",
    "officialTitle": "Scientific Research on Exploring a Breast Cancer Early Screening Model Using cfDNA Multi-omics Liquid Biopsy Technology Based on Deep Learning",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Breast Fibroadenoma, Breast Hypoplasia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 480,
    "primaryOutcomeMeasure": "Evaluate the sensitivity and specificity of the early detection model for breast cancer screening",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients \u226518 years old and \u226470 years old;\n2. Plasma of the participant can be obtained;\n3. Willing to sign the informed consent;\n4. Meet one of the following criteria:\n\n4.1)Patients diagnosed with invasive breast cancer or carcinoma in situ of the breast for the first time; 4.2)Patients with breast fibroma or breast adenosis and breast fibrocystic hyperplasia;\n\nExclusion Criteria:\n\nIn any of the following situations, subjects should not participate in the trial:\n\n1. Pregnant or lactating;\n2. Unable to obtain the participant's plasma;\n3. Patients with other types of malignant tumors diagnosed by pathology within 5 years before enrollment;\n4. The patients had suspected imaging (B-ultrasound, CT, etc.) of other malignant tumors within the past 1 year after enrollment, but no pathological confirmation;\n5. Received any blood product transfusion in the past 30 days;\n6. Participants considered by the investigator to be inappropriate to participate in this research-type clinical trial.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}